Empower: Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy

Sponsor
University of Alberta (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05254678
Collaborator
(none)
30
1
2
9.9
3

Study Details

Study Description

Brief Summary

The primary purpose of this study is to determine the feasibility of our proposed intervention approach involving (1) an integrated physiotherapy and exercise intervention for individuals with breast cancer who are undergoing chemotherapy and (2) delivery of programming via an electronic health (eHealth) application. The secondary objective is to determine the efficacy of the program on upper extremity outcomes, general physical fitness, cancer treatment-related symptoms and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: general exercise
N/A

Detailed Description

EMPOWER is a multi-methods feasibility randomized controlled trial. The study will recruit a minimum of 30 individuals with breast cancer who are undergoing adjuvant chemotherapy following surgery for breast cancer. The study will be conducted in two phases:

Phase I: Randomized Controlled Feasibility Trial The aim of this phase is to determine the feasibility and preliminary efficacy of a 10-week integrated physiotherapy and exercise intervention compared to an exercise intervention alone.

Phase II: Qualitative Study The aim of this phase is to evaluate the acceptability of the Healthy Eating, Active Living and Mindful Energy (HEAL-ME) Research App design, program delivery, program components and perceived effectiveness of the intervention at the level of the participant.

PHASE I: Randomized Controlled Feasibility Trial A cluster randomized controlled trial design will be used to randomize 6-8 cohorts involving 4-6 individuals with breast cancer to one of two groups: 1) Comparison group: general exercise intervention + education; and 2) Experimental group: integrated physiotherapy and general exercise intervention + education. The study will be carried out over a 10-week period. The outcome measures will be assessed at baseline and at 10 weeks.

Randomization: An independent researcher will generate the randomization sequence using a computer-generated randomization module within the Trial's REDCap database. Randomization will occur following baseline testing of all individuals in the respective cohort.

Interventions:
Group 1 (Comparator): HEAL-ME delivered General Exercise:

Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via virtual platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application. Exercise regimen: The exercise regimen follows the general principles of overload, progression, and specificity. The exercise program consists of full body exercise (e.g., comprising aerobic, resistance training, core stability, balance and flexibility training) a minimum of 2 times per week (one group virtual session and one independent self-directed session). Education: educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the exercise expectations, behavior change strategies, home exercise equipment and how to exercise safely.

Group 2 (Experimental): HEAL-ME Integrated Physiotherapy and exercise:

Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via virtual platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules. Integrated physiotherapy and exercise regimen: The integrated physiotherapy and exercise regimen will follow the exercise regimen as described in Group 1. For this group, breast cancer specific shoulder range of motion and stretching exercises will be incorporated into the warm-up and cool-down components of both group and individual exercise sessions. Education: educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the benefits of exercise during chemotherapy for breast cancer, exercise behavior change strategies, and how to exercise safely.

Blinding An independent assessor, who is blinded to the group assignment will carry out all the measurements. Training of the assessor will be conducted on the measurement procedures related to the upper body and fitness outcome measurement protocols prior to study initiation.

PHASE II: Assessment of HEAL-ME App Design, Acceptability, and Program Components The app design, acceptability, and program components will be assessed following completion of the study through focus groups and semi-structured interviews to explore the experiences of individuals randomized to the HEAL-ME experimental group. The purpose of this phase is to assess different aspects of HEAL-ME related to the program delivery, different components contents, and time commitment. The results of this phase will inform further development of the HEAL- ME breast cancer module.

Phase II Data Collection Focus Groups: E-intervention group participants will be invited to participate in a focus group or semi-structured interview session that aim to capture participant perspectives and experiences, as well as any facilitators or barriers to use of the HEAL-ME application.

Qualitative Data Analysis The focus groups discussions will be audio recorded and transcribed. Two researchers will read and then reread the transcripts for accuracy against the audio recordings. The investigators will conduct an inductive content analysis to capture the participants' views about the program's acceptability and usability and ways to refine it. The inductive approach will enable a descriptive evaluation of the program from the participant's view. Two researchers will independently analyze the content of the focus group transcripts to identify evidence related to research objectives. Using the thematic analytic approach, the investigators will follow different processes described by Braun and Clarke. The data will be analyzed line by line by the researchers independently to identify patterns and key themes with example quotes from the data. Codes for similar meanings and highlighted terms will be developed, examined, and refined if necessary to identify the most expressive codes related to the research objectives. The process will be repeated a few times until concrete themes emerge and no further themes are identified. The generated themes will be reviewed and verified by a third researcher in order to increase the validity of the findings. Any coding discrepancies will be discussed and reconciled. Conceptual themes will be inductively originated from analysis through generating initial codes, followed by sub-themes, and finally, an overarching theme.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled feasibility trialRandomized controlled feasibility trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Independent assessors will be used for collection of objective outcomes. The independent assessors will be blinded to group allocation.
Primary Purpose:
Supportive Care
Official Title:
Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy (EMPOWER): A Randomized Controlled Feasibility Trial
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard exercise program

Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.

Behavioral: general exercise
A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.
Other Names:
  • physiotherapy
  • Experimental: Integrated physiotherapy and exercise

    Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.

    Behavioral: general exercise
    A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.
    Other Names:
  • physiotherapy
  • Outcome Measures

    Primary Outcome Measures

    1. Completion rate [10 weeks]

      Defined as >70% participants completing at least 70% of exercise sessions and the post-study assessment

    Secondary Outcome Measures

    1. Recruitment rate [one year]

      Percentage of participants eligible who consent to participate in the study

    2. Attendance rate [10 weeks]

      Percentage of completed exercise and education modules

    3. Program Satisfaction [10 weeks]

      Program Satisfaction Questionnaire

    4. Symptoms [10 weeks]

      Edmonton Symptom Assessment System

    5. Health-related Quality of Life [10 weeks]

      Functional Assessment of Cancer Therapy -breast (FACT-B+4)

    6. Fatigue [10 weeks]

      Functional Assessment of Cancer Therapy - fatigue subscale (FACIT-F)

    7. Physical Activity [10 weeks]

      Godin Leisure Time Exercise Questionnaire

    8. Cost-effectiveness [10 weeks]

      EuroQol 5-Dimension 5-Level (EQ-5D-5L)

    9. Walking endurance [10 weeks]

      Six-minute walk test

    10. Lower body strength [10 weeks]

      Thirty second sit-to-stand

    11. Flexibility Shoulder Flexion [10 weeks]

      Active Shoulder Range of Motion: flexion

    12. Flexibility Shoulder Abduction [10 weeks]

      Active Shoulder Range of Motion: abduction

    13. Flexibility Shoulder External Rotation [10 weeks]

      Active Shoulder Range of Motion: external rotation

    14. Flexibility Shoulder Internal Rotation [10 weeks]

      Active Shoulder Range of Motion: internal rotation

    15. Flexibility Shoulder Horizontal Abduction [10 weeks]

      Active Shoulder Range of Motion: horizontal abduction

    16. Flexibility lower body [10 weeks]

      Sit-and-reach

    17. Balance [10 weeks]

      One-leg Stance Test

    18. Arm volume [10 weeks]

      Perometry for the measurement of lymphedema

    19. Body weight [10 weeks]

      Measurement of weight in kgs

    20. Body height [10 weeks]

      Measurement of height in cms

    Other Outcome Measures

    1. Grip strength (optional) [10 weeks]

      Dynamometry

    2. Core muscular endurance (optional) [10 weeks]

      Plank endurance test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • adult females with a diagnosis of breast cancer (Stage Ic-III);

    • be able to participate in mild levels of activity at minimum;

    • have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy;

    • starting adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks post-operatively up to the point of the start of the second cycle of chemotherapy);

    • speak and understand English.

    Exclusion Criteria:
    • unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta;

    • do not have regular access to the internet and a smart device or computer in the home.

    • have undergone, or are scheduled to undergo, neoadjuvant chemotherapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alberta/ Cross Cancer Institute Edmonton Alberta Canada T6G 2G4

    Sponsors and Collaborators

    • University of Alberta

    Investigators

    • Principal Investigator: Margaret McNeely, University of Alberta

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Alberta
    ClinicalTrials.gov Identifier:
    NCT05254678
    Other Study ID Numbers:
    • HREBA.CC-21-0429
    First Posted:
    Feb 24, 2022
    Last Update Posted:
    Jul 27, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Alberta
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2022